Australian scientists have discovered how the immune system can control melanoma, a mechanism which could be used to enhance cancer treatments.
Published today in Nature, Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Telethon Kids Institute researchers investigated the role of a particular immune cell, tissue-resident memory T (TRM) cells, in controlling melanoma.
TRM cells were able to control the tumour in the mice for the life of the animal, which is likely to equate to decades of protection in humans.
University of Melbourne PhD student, Simone Park from the Doherty Institute, created an imaging model to study TRM cells’ and melanoma in a mouse model.
“Using a special microscope, we could see individual melanoma cells sitting in the skin of the mouse, and could watch the T cells move through the skin, find the melanoma cells and control the growth of those cells,” Ms Park explained.
One of the main issues for cancer patients is that there is always a risk that the tumour can come back years later, after surgery or chemotherapy.
Previous research has shown that small numbers of cancer cells persist in the body after treatment and that the immune system probably keeps the cancer cells under control but this study in mice could study the immune system directly. This is work that could never be done in people.
“I was able to see through moving images that these TRM cells are important for maintaining the control of the tumour cells; if you remove the TRM cells you have a break in that control and the cancer can start to grow back again,” Ms Park said.
“If you could make more of these TRM cells through immunotherapies, or enhance the activity of those that are already there in some way, you could boost anti-tumour immunity.”
Senior author on the paper, University of Melbourne Associate Professor Thomas Gebhardt, Laboratory Head at the Doherty Institute, said an increase of TRM cells has already been associated with better outcomes in cancer patients, but the way they work to suppress tumours has remained unknown.
“The principal of cutting-edge immunotherapies currently in clinical practise is that they generate a T-cell response. But if we can hone in on one type of T-cell – the TRM cells specifically, we could have an even bigger impact on stopping cancers from coming back,” Associate Professor Gebhardt said.
“We now have a much better understanding of which T-cells are important in controlling skin cancers and how those cells are working but there is still much more work to do to make these cells work even better,” Associate Professor Gebhardt said.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- AFL 2019: Jarryd Roughead retires, cancer, 2016 melanoma, treatmenton August 16, 2019 at 10:33 am
Retiring Hawthorn champion Jarryd Roughead has reflected on his 2016 cancer battle and how he speaks to people going through similar experiences. In May 2016, Roughead was diagnosed with a recurrence ...
- Bend is a ‘perfect storm’ for melanomaon August 16, 2019 at 12:01 am
For more details on how to check your skin or how to get involved in the War on Melanoma campaign, visit startseeingmelanoma.com Wearing sunscreen today? If the answer is no, maybe you should be.
- MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyon August 15, 2019 at 1:38 pm
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for ...
- A new treatment for advanced melanoma patients on Coast Liveon August 14, 2019 at 12:01 pm
HAMPTON ROADS, Va. - Melanoma is the most serious and life-threatening type of skin cancer. It is almost always treatable when caught early, but if it metastasizes, or spreads to other parts of ...
- Genetic test helped Utahns at risk for melanoma change behavior, study findson August 9, 2019 at 5:27 pm
SALT LAKE CITY — When people know they have a high genetic risk of melanoma, they are more likely to protect themselves from the sun, according to a new study. "For most genes that have been found for ...
- Combo Tx for Melanoma Ups CV Riskon August 9, 2019 at 11:11 am
Dual BRAF and MEK inhibition therapy for melanoma may carry certain cardiovascular harms, according to a meta-analysis. Across five randomized trials with a total of 2,317 patients, the addition of ...
- Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccineon August 6, 2019 at 3:29 am
Dissonant signaling, which can deafen the immune system to cancer, can be replaced by something more harmonious—and therapeutic—if immunotherapies silence a note, sound another, or play an especially ...
- Scientists demonstrate a new nano-vaccine preventing the spread of melanomaon August 5, 2019 at 9:41 pm
A new nano-vaccine both slowed the progression of skin cancer in mice with a primary melanoma, and prevented its initial onset in healthy mice(Credit: vitanovski/Depositphotos) A new nano-vaccine ...
- Man bikes across America to raise awareness for melanomaon August 5, 2019 at 4:23 pm
A Waukesha County man is biking across America to raise money and awareness about melanoma. He's riding for his sister Barbie. She lost her battle with melanoma last year at the age of 58.
- Skin cancer nano-vaccine protects mice from deadly melanoma cellson August 5, 2019 at 2:12 pm
Melanoma, the most deadly skin cancer, may one day be prevented and treated using a simple vaccine. Researchers with Tel Aviv University have published the results of their work with nanoparticles and ...
via Bing News